Table 1 Clinical data of MS patients and non-neurological controls
Case | Age (years) | MS type | Sex | Post-mortem delay (h:min) | Disease duration (years) | Lesion stages |
|---|---|---|---|---|---|---|
MS 1 | 73 | ND | m | 6:45 | 26 | CIA |
MS 2 | 63 | PP | m | 7:05 | 25 | CA |
MS 3 | 56 | SP | m | 8:00 | 27 | CIA |
MS 4 | 66 | ND | m | 7:45 | ND | A |
MS 5 | 41 | PP | m | 7:20 | 14 | A, CA |
MS 6 | 49 | SP | m | 8:00 | 25 | CIA |
MS 7 | 66 | PP | m | 7:30 | 26 | 2*CA |
MS 8 | 61 | SP | m | 9:15 | 30 | 3*CA, CIA |
MS 9 | 44 | PP | m | 12:00 | 13 | CA |
MS 10 | 44 | SP | m | 10:15 | 22 | CA |
MS 11 | 54 | PP | m | 8:15 | 15 | 3*A |
MS 12 | 45 | AMS | m | ND | 1Â week | 3*A, CA, CIA |
MS 13 | 35 | AMS | m | ND | 6Â weeks | 5*A, 2*CIA |
MS 14 | 40 | RR | f | ND | 10 | A |
MS 15 | 34 | AMS | f | ND | 0,3 | A |
MS 16 | 78 | AMS | m | ND | 0,2 | A, CA |
MS 17 | 41 | SP | m | ND | 10,6 | A |
MS 18 | 46 | SP | f | ND | 37 | CA, CIA |
MS 19 | 51 | AMS | f | ND | 0,5 | A, 3*CA |
Ctrl 1 | 66 | NA | f | 7:00 | NA | NA |
Ctrl 2 | 71 | NA | m | 8:55 | NA | NA |
Ctrl 3 | 58 | NA | m | 5:15 | NA | NA |
Ctrl 4 | 62 | NA | m | 7:20 | NA | NA |
Ctrl 5 | 78 | NA | m | 17:40 | NA | NA |
Ctrl 6 | 51 | NA | f | 5:36 | NA | NA |
Ctrl 7 | 70 | NA | m | ND | NA | NA |
Ctrl 8 | 46 | NA | m | ND | NA | NA |
Ctrl 9 | 37 | NA | m | ND | NA | NA |
Ctrl 10 | 39 | NA | f | ND | NA | NA |